In contrast, the highest FGF23 quartile was associated with a higher risk of infectious events (HR, 1.57 versus the lowest quartile; 95% CI, 1.13-2.18), cardiac events (HR, 1.49; 95% CI, 1.06-2.08), and allcause mortality (HR, 1.50; 95% CI, 1.07-2.12) in fixed-covariate Cox models. The addition of inflammation markers into the statistical models did not attenuate these associations. Thus, disordered mineral metabolism may affect outcomes in chronic hemodialysis patients. Cardiac events are the major cause of death in hemodialysis patients, accounting for approximately 40-50% of deaths. 1,2 Similarly, infections remain a very common cause of morbidity and mortality. [3][4][5] Several nontraditional risk factors may contribute to these two important clinical outcomes in this high-risk population, such as CKDassociated mineral and bone disorder 6 which includes a wide range of abnormalities in vitamin D metabolism 7-9 and phosphate homeostasis. 10,11 Lower serum levels of both 25-hydrovitamin D (25(OH)D) and 1,25-dihydroxyvitamin D (1,25(OH) 2 D) have been associated with increased mortality within 90 days of initiating hemodialysis. 8 However, no studies have evaluated annual repeated measures of vitamin D analytes in